Cencora Stock Forecast
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
COR analyst consensus
Consensus (14 analysts)
buy
Avg. price target
$382.42+12.78%
- Strong buy 3
- Buy 7
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 14 Wall Street analysts covering Cencora (2026-11-17), 10 rate the stock a buy or strong buy, 4 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $382.42, with a high estimate of $414.00 and a low estimate of $330.00. The average target implies upside of 12.8% from the current price of $339.09.
The spread between the highest and lowest targets is 25.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for COR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 21% |
| Buy | 7 | 50% |
| Hold | 4 | 29% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-11-17.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $330.00 | -2.68% |
| Average target | $382.42 | +12.78% |
| High target | $414.00 | +22.09% |